MAPT and Alzheimer disease: Since the plasma p-tau181 and p-tau181/Aβ42 ratio were significantly associated with amyloid pathology,54,55 tau pathology56,57 and brain atrophy,55 our results supported a higher Alzheimer's disease pathology burden in EOAD.